Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion by | Ago 9, 2024 | UncategorizedMerck has struck a deal worth up to $1.3 billion to buy an investigational drug targeting B-cell associated diseases.
Algonquin Power to Sell Renewable Energy Business for $2.5 Billion by | Ago 9, 2024 | UncategorizedAlgonquin Power & Utilities has agreed to sell its renewable energy business for $2.5 billion as it transforms into a pure-play regulated utility.
Health Care Roundup: Market Talk by | Ago 9, 2024 | UncategorizedSandoz, Novo Nordisk and more in latest Market Talks covering the Health Care sector.
Eli Lilly Is Gaining on Novo Nordisk in the Obesity Race by | Ago 9, 2024 | UncategorizedDespite a late start, the advantage is shifting toward the U.S. company.
‘I’d Rather Be Sad Than Dead’: Heartbroken Swifties Commiserate in Vienna by | Ago 9, 2024 | UncategorizedDevoted fans are finding comfort by banding together to belt the Taylor Swift’s tunes in town squares and churches.
What Economic Dangers Is the Bond Market Pricing In? by | Ago 9, 2024 | UncategorizedEven more so than stocks, bonds are often seen as an economic bellwether.
